FRCA Notes


Knee Arthroplasty

This topic hasn't featured as a past Final SAQ/CRQ, although principles of ERAS for elective lower limb surgery has been.

"Explains the difference in anaesthetic and surgical complexity between primary and secondary lower limb arthroplasty" is probably the most relevant curriculum item.

Resources




Primary Revision
Duration Usually <2hrs
Suitable for a single-shot spinal
Longer and less predictable
May exceed spinal duration
Blood loss Moderate
TXA usually sufficient
Greater
Consider cell salvage ± blood products
Pain Motor-sparing blocks + LIA More severe
Denser blocks, catheters, epidural/CSE or IT morphine
Pathway ERAS
Same-day discharge possible
Longer stay
Delayed mobilisation may be planned
Other Infection (staged procedures)
Bone loss
Extensive surgical exposure


Perioperative Management of the Patient Undergoing Elective Knee Arthroplasty


Considerations

  • Patients often have limited mobility and chronic moderate-severe pain
  • Mean age 69yrs
  • Mean BMI 31kg/m2
  • Surgical developments relevant to anaesthesia:
    • Unicompartmental knee replacement for younger patients, shorter operative time, less blood loss and shorter stay
    • Robotic-assisted surgery allows improved alignment and less blood loss, but longer operative time

ERAS programmes

  • Use of ERAS programmes for those undergoing knee arthroplasty:
    • Reduces length of stay, especially in healthier patients
    • No increase in perioperative complications
    • Reduces blood transfusion rates
    • Reduces complication rate, including mortality

  • Same-day discharge knee arthroplasty achieves comparable results to inpatient surgery in selected patients
    • Requires protocolised practice, strong MDT working and consistent communication throughout

Patient education and prehabilitation

  • Education is a cornerstone of ERAS ('joint schools'):
    • Reduces anxiety and improves engagement with rehabilitation
    • Helps manage patient expectations
    • Education about post-operative pain can reduce opioid consumption by half
  • Home-based prehabilitation programmes may reduce perioperative pain and improve function

Optimisation

  • Smoking cessation for at least 4 weeks
  • Alcohol reduction in those who drink heavily
  • Anaemia: assess and manage all patients with Hb <130g/L regardless of sex
    • Pre-operative anaemia independently predicts complications, longer stay and mortality
  • Check renal function to guide NSAID, opioid and TXA use
  • Identify risk factors for persistent post-surgical pain and tailor the analgesic plan:
    • High pre-operative pain, pain catastrophising, anxiety and depression
    • Younger age, female sex
    • Moderate-severe acute post-operative pain

  • Reduce perioperative fasting time
    • Use 'sip-to-send' policy
    • Pre-operative carbohydrate loading
  • Pre-medication: paracetamol ± NSAID/COX-2 inhibitor with PPI

Monitoring and access

  • Association of Anaesthetists standard monitoring
  • Patient usually positioned supine so no need to keep IV access to one side

Tourniquet

  • Routine tourniquet use is now discouraged as it is associated with:
    • Increased post-operative pain
    • Serious compression events: nerve injury, limb ischaemia and compartment syndrome
  • Blood conservation strategies are therefore more important (see below)

Anaesthetic technique

  • Both neuraxial and general anaesthesia are accepted
  • Choice is individualised to comorbidities, surgical complexity, expected duration and patient preference
  • Neuraxial anaesthesia is frequently favoured as it is associated with lower odds of several complications:
Complication (neuraxial vs. GA) Odds ratio
Critical care admission 0.17
Blood transfusion 0.44
Pulmonary complications 0.66
Pneumonia 0.67
Acute kidney injury 0.67
Deep vein thrombosis 0.77
Pulmonary embolism 0.79
All infections 0.80

Neuraxial anaesthesia

  • Spinal anaesthesia is preferred over epidural or CSE techniques
  • Hyperbaric solutions have a faster onset and faster resolution of motor block than isobaric solutions
    • Hyperbaric 2% prilocaine: rapid onset, early resolution and minimal urinary retention so suitable for procedures up to ~90mins and same-day discharge
    • Bupivacaine or levobupivacaine for longer procedures, typically 7.5-10mg e.g. 2ml 0.5% heavy bupivacaine, which does not appear to compromise early mobilisation or discharge
    • Chloroprocaine may be too short-acting even for experienced surgical hands

  • Intrathecal opioids are not routinely recommended:
    • Side-effects: pruritus, PONV, urinary retention and sedation
    • Greater post-operative monitoring requirements
    • Little incremental benefit where motor-sparing regional anaesthesia is used
    • Morphine 100μg may be considered in selected patients where difficult pain is anticipated (e.g. revision surgery, complex pain syndromes)
    • PROSPECT guidance limits IT morphine this to inpatients in whom neither ACB nor LIA is possible
    • Intrathecal diamorphine is widely used in the UK but evidence in TKA is limited

  • Epidural/CSE use has declined due to hypotension, urinary retention, delayed mobilisation and catheter logistics; may still have a role in complex or revision cases

  • ± procedural sedation
    • E.g. propofol TCI at the minimum effective dose
    • Patient-controlled procedural sedation is associated with fewer sedation-associated adverse events than anaesthetist-led TCI (BJA, 2021)

General anaesthesia

  • A reasonable alternative where spinal anaesthesia is contraindicated, declined or likely to be of insufficient duration
  • Use agents with rapid onset and offset to enable early mobilisation
  • No overall superiority of either technique:
    • TIVA: less PONV, emergence agitation and cognitive dysfunction
    • Volatile: faster emergence
  • Requires additional analgesia, e.g. from regional techniques, in addition to a multimodal regimen

Regional anaesthesia

  • Motor-sparing techniques are recommended and proximal blocks which hinder early mobilisation (femoral, sciatic) are discouraged
  • PROSPECT recommends single-shot adductor canal block + surgical local infiltration analgesia (LIA) as the standard approach
  • Further options include genicular nerve blocks, anterior femoral cutaneous nerve blocks and iPACK (although iPACK does not add benefit to surgical LIA)
  • Dense femoral ± sciatic blocks may be appropriate for complex revisions, planned delayed mobilisation or severe pre-operative pain
  • See motor-sparing blocks for knee arthroplasty for anatomy, techniques and evidence

Blood management

  • Tranexamic acid is the most effective intervention for reducing blood loss in knee arthroplasty
    • Greatest benefit with higher cumulative doses and combined routes (IV, oral, intra-articular)
    • Practical regimen: 1g IV at the start of surgery + 1-2g intra-articular after the final washout, before closure
    • Maximum total 3g with normal renal function
    • Severe renal impairment: reduce IV dose to 500mg and omit intra-articular TXA
    • Surgical requests regarding timing, dose and route vary
  • Cell salvage where major haemorrhage is anticipated, e.g. revision surgery

Analgesia

  • Knee arthroplasty is associated with more significant pain than hip arthroplasty owing to more extensive osteotomy and splitting of the quadriceps muscle
  • High quality analgesia is associated with reduced time to mobilisation, reduced length of rehabilitation and reduced length of stay

  • Paracetamol
  • NSAID or COX-2 inhibitor (if no contraindication)

  • Dexamethasone ≥10mg IV
    • Reduces pain, opioid consumption and PONV; effects most pronounced in the first 24hrs
    • Some centres use higher doses, although 1mg/kg conferred no additional benefit over 0.3mg/kg in low pain responders (BJA, 2023)
    • A second IV dose 24hrs post-op. may confer additional benefit over a single dose
    • Single doses appear safe in diabetes but monitor for transient hyperglycaemia

  • Consider intra-operative adjuncts on a case-by-case basis:
    • Ketamine 0.1-0.3mg/kg IV, e.g. in chronic opioid users; caution in those at risk of delirium
    • Magnesium 50mg/kg IV over 30mins

Not recommended

  • Gabapentinoids: no clinically meaningful analgesic benefit and well-recognised adverse effects
  • α2-agonists (e.g. dexmedetomidine): inconsistent evidence

Care bundle

  • Antibiotics as per local policy
    • Intraosseous vancomycin may reduce perioperative joint infection
  • PONV prophylaxis, e.g. dexamethasone + ondansetron 4mg
  • Judicious IV fluids
  • Vasopressor (e.g. metaraminol) to keep blood pressure within 20% of baseline
  • Avoid drains and urinary catheters unless essential

Recovery

  • Early mobilisation, ideally on the day of surgery, with physiotherapy started within 24hrs
  • Discharge based on objective criteria rather than set timelines
  • Early oral intake and resumption of normal diet with avoidance of routine post-operative IV fluids
  • Delirium prevention in those >65yrs: effective analgesia, minimal sedatives, early mobilisation, nutrition, sleep, glasses and hearing aids
  • VTE prophylaxis per local policy
    • Early mobilisation within ERAS pathways supports a more individualised approach
    • NICE suggests aspirin or LMWH for 14 days (or a DOAC) after knee replacement

Analgesia

  • Regular paracetamol 1g Q6H
    • Reduces post-operative opioid consumption by 16-26% (NNT 3.6)

  • NSAID with PPI cover if not contraindicated
    • E.g. ibuprofen 400mg Q8H, celecoxib 200mg BD
    • Avoid in the first 48hrs if eGFR<60/CKD3
    • Avoid entirely if eGFR<30/CKD4
    • Avoid diclofenac or -coxibs in those with cardiovascular disease

  • Consider nefopam in those not able to have NSAIDs

  • Reserve opioids for rescue analgesia
    • Oral, immediate-release opioids only as modified-release opioids are no longer recommended for post-operative pain
    • Opioid PCA is discouraged due to sedation, nausea and delayed mobilisation
    • Avoid morphine-based opioids in renal failure and use oxycodone instead
  • Laxatives

Pain

  • Severe acute post-operative pain in up to 36%
  • Persistent post-surgical pain in ~15%
    • Early identification of at-risk patients and referral of complex cases to pain services may reduce long-term disability
  • Chronic opioid use (any refill 3-6 months post-op.) ~13% ± chronic opioid dependence <1%
    • Peripheral nerve blocks (single-shot or catheter) made no clinically meaningful difference to either outcome (BJA, 2025)

Acute kidney injury

  • Overall rate 10-20%
  • Risk factors: hypertension, diabetes, increasing age and ACE-I/ARB use
    • Diabetes combined with ACE-I/ARB use doubles the risk

Other

  • Post-operative delirium and neurocognitive disorder, especially >65yrs
  • VTE
  • Tourniquet-related: nerve injury, limb ischaemia, compartment syndrome
  • Falls, particularly with quadriceps weakness from femoral nerve block